CYRX
Cryoport, Inc. Health Care Pharmaceutical Preparations Russell 3000
$17.29Close
$861.9MMarket cap
$7.72 – $18.6452-week range
Nov 5, 2026Next report · after the close
Highlights
Strengths
- In a stage-2 uptrend all 8 trend conditions pass
- Leading the market RS 93 · stronger than 93% of stocks over 12 months
Cautions
- Earnings shrinking EPS −108% year on year
- Results soon Nov 5, 2026, in 4 days
- Financial distress Altman Z″ in the distress zone
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
7%
1wk
down 3.8%
price change
1mo
down 0.6%
price change
12-month return
up 92%
market up 11% ·
its own up 76%
F-score
5 / 9
Mixed
Altman Z
1.19
Elevated risk
P/E
11.0×
price / earnings
PEG
—
P/E / EPS growth
P/B
1.7×
price / book
Earnings yield
down 4.6%
EBIT / enterprise value
Cheaper than
35%
of the market · expensive
Revenue growth
up 12%
year on year
EPS growth
down 108%
latest quarter
Sales growth
up 8%
latest quarter · -9 pts
ROE
up 17%
return on equity
Free cash margin
down 14%
-$25.0M FCF
D/E
0.37
long-term debt / equity
Net debt / EBITDA
—
Interest cover
—EBIT / interest
Piotroski tests
- operating cash flow is negative
- profits not fully backed by cash
- took on more long-term debt
- short-term liquidity weakened
- profitable on its assets
- profitability improving
- no new shares issued
- gross margin widened
- assets working harder
Repair signals
- Gross margin 44.4% → 47.1%
- Revenue reaccelerating (-7% then +12%)
Trade setup
ATR%
4.2%
$0.72 a day · 2×ATR $15.84
RS
93 / 99
vs the universe
Trend
8 / 8
trend template
Relative volume
1.5×
vs 50-day average
Up/down volume
0.90
50 sessions
Implied move
—
no option chain · report Nov 5, 2026
Trend template · 8 of 8
Screen verdict
Did not qualify for any screen.
Warning signs
- Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
- Profit not backed by cash Reported profit of $78.3M came with -$8.6M of operating cash flow. Profit that cash does not follow is the classic signature of aggressive accounting.
Last reported
Aug 6, 2026
Results reaction
Aug 6, 2026-1% vs market2 sessions after results
Financials
- Gross 47%
- Net 44%
- Free cash -14%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $78.7M | $222.6M | $237.3M | $168.7M | $156.8M | $176.2M |
| Gross margin | 46% | 43% | 44% | 45% | 44% | 47% |
| Operating income | -$30.0M | -$17.8M | -$31.9M | -$100.5M | -$121.7M | -$36.8M |
| Net income | -$32.7M | -$275.5M | -$37.3M | -$99.6M | -$114.8M | $78.3M |
| Net margin | -42% | -124% | -16% | -59% | -73% | 44% |
| Earnings per share | -$0.85 | -$6.00 | -$0.76 | -$2.04 | -$2.33 | $1.56 |
| Free cash flow | -$23.8M | -$15.8M | -$24.0M | -$39.5M | -$33.6M | -$25.0M |
| Free cash margin | -30% | -7% | -10% | -23% | -21% | -14% |
| Cash | $36.9M | $139.1M | $29.2M | $35.2M | $34.1M | $250.5M |
| Long-term debt | $115.0M | $1.1M | $355,000 | $1.3M | $1.1M | $186.2M |
| Shareholders' equity | $382.7M | $641.8M | $555.8M | $489.0M | $401.9M | $502.6M |
| Shares outstanding | 39.84m | 49.62m | 48.33m | 48.97m | 49.91m | 49.85m |
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Aug 6, 2026 | Quarterly ↗ | Jun 30, 2026 | 37d |
| May 5, 2026 | Quarterly ↗ | Mar 31, 2026 | 35d |
| Mar 5, 2026 | Annual ↗ | Dec 31, 2025 | 64d |
| Nov 6, 2025 | Quarterly ↗ | Sep 30, 2025 | 37d |
| Aug 12, 2025 | Quarterly ↗ | Jun 30, 2025 | 43d |
| May 8, 2025 | Quarterly ↗ | Mar 31, 2025 | 38d |
| Mar 7, 2025 | Annual ↗ | Dec 31, 2024 | 66d |
| Nov 7, 2024 | Quarterly ↗ | Sep 30, 2024 | 38d |
| Aug 8, 2024 | Quarterly ↗ | Jun 30, 2024 | 39d |
| May 8, 2024 | Quarterly ↗ | Mar 31, 2024 | 38d |
| Mar 13, 2024 | Annual ↗ | Dec 31, 2023 | 73d |
| Nov 9, 2023 | Quarterly ↗ | Sep 30, 2023 | 40d |
Current reports
| Filed | Disclosed |
|---|---|
| Aug 6, 2026 | Results ↗ |
| Jun 9, 2026 | Shareholder vote ↗ |
| May 4, 2026 | Results ↗ |
| Mar 3, 2026 | Results ↗ |
| Nov 4, 2025 | Results ↗ |
| Aug 6, 2025 | Results ↗ |
| Jun 13, 2025 | Acquisition or disposal · Regulation FD ↗ |
| Jun 10, 2025 | Shareholder vote ↗ |
| May 7, 2025 | Results ↗ |
| Mar 31, 2025 | Material agreement · Regulation FD ↗ |
| Mar 4, 2025 | Results ↗ |
| Nov 7, 2024 | Results ↗ |